Novant Health to buy three Tenet hospitals in South Carolina for $2.4B
Proceeds from the purchase will go toward paying debt, according to Tenet.
Novant Health to buy three Tenet hospitals in South Carolina for $2.4B Read More »
Uncategorized
Mayo Clinic posts $4.5B in operating revenue for Q3
After a rocky 2022, the Minnesota-based nonprofit has posted a net income in three consecutive quarters on sustained volumes and moderating expenses.
Mayo Clinic posts $4.5B in operating revenue for Q3 Read More »
FDA acts on industry call for clarity about scope of device shortage reporting rules
The agency posted a final guidance and draft guidance on medical device shortage reporting requirements, addressing industry concerns.
FDA acts on industry call for clarity about scope of device shortage reporting rules Read More »
FDA seeks feedback on racial bias of pulse oximeters, convenes advisory committee
The agency published a paper on improving the evaluation of pulse oximeters to take skin pigmentation into account.
FDA seeks feedback on racial bias of pulse oximeters, convenes advisory committee Read More »
Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access
Kazemi hopes anyone with diabetes will be able to access the technology, even people who don’t take insulin.
Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access Read More »
Top FDA official Woodcock to retire early next year
The 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer’s therapy and muscular dystrophy drugs.
Top FDA official Woodcock to retire early next year Read More »
Importancia de los productos desechables sanitarios
En la búsqueda constante de soluciones prácticas y eficientes para mejorar la higiene y comodidad en nuestra vida diaria, los productos desechables sanitarios se han posicionado en un imprescindible. Desde pañuelos de papel hasta guantes médicos y protectores para el cuer …
Importancia de los productos desechables sanitarios Read More »
Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
Astellas Pharma Inc. and Pfizer Inc. announced that the companies received an approval by the U.S. Food and Drug Administration of a supplemental New Drug Application for XTANDI®, following FDA expedited development and review programs, based on results from the Phase 3 EMBARK trial.
Disipar el estrés gracias al diamond painting
El estrés se puede convertir en una carga que puede afectar a cualquiera de nosotros. Afortunadamente, existen numerosos métodos para combatirlo y evacuar las tensiones que llevamos dentro. Entre las diferentes técnicas que pueden ayudarte a relajarte, está el d …
iZafe Group’s Quarterly Report Q3, July-September 2023
iZafe Group AB presents its report for the third quarter on November 17.
iZafe Group’s Quarterly Report Q3, July-September 2023 Read More »